Director/PDMR Shareholding

October 12, 2018

The Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on the 9 and 10 October 2018 it purchased 100,000 and 180,790 Ordinary Shares of 1p, respectively, in the capital of the Company ("Ordinary Shares") at 3.66p per Ordinary Share (the “Purchase”).  Following the Purchase, Vulpes has a total direct and indirect interest in 61,132,777 equivalent to 20.71% of Proteome Sciences' total issued share capital.

Back to News